EuroPCR 2023: Late-Breaking Science Video Collection

Up Next

EuroPCR 2023: Late-Breaking Science Video Collection

Average (ratings)
No ratings
Your rating
About the episode

Learn the key take-home messages from EuroPCR 2023 with View from the Thoraxcenter hosts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL).

In this dynamic video review, Dr Daemen and Prof Van Mieghem cover the top late-breaking science, offering insight into how they will incorporate the data into their clinical practice.

What are the top trials of EuroPCR 2023? What are the considerations for practice? What is next?

00:44: EBC TWO 5-Year Follow-Up
00:59: EBC Main 3-Year Follow-Up
01:33: KISS Trial
03:53: Repeat TAVR
05:24: Chimney Stenting vs BASILICA to Prevent TAVR-related Coronary Obstruction
08:36: Prospective MITRAL Trial
10:05: DRAGONFLY-DMR
11:32: FAST-TAVI II
13:57: EUROSHOCK
17:01: REFORM
18:30: TRANSFORM I
20:02: BIOMAG-1
22:15: ABSORB IV
23:38: DEFINE-FLAIR
25:31: FAME III
26:59: SMART

Get a critical review of the EuroPCR 2023 late-breaking and featured data!

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

 

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

 

Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.

 

Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023. 

More from this programme

Part 2

View from the Thoraxcenter

In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023. 

Part 3

Highlights Reviews

Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.

Part 4

Behind the Heart

Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Full Professor of Interventional Cardiology

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

 

Academic History

Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.